A dose of 75 μg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 μg/kg/d in adults with immune thrombocytopenic purpura-Reference-Cited by-同舟云学术

A dose of 75 μg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 μg/kg/d in adults with immune thrombocytopenic purpura

Published:2001-03 Issue:4 Volume:112 Page:1076-1078
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Newman Gregg C.,Novoa Maria V.,Fodero Erin M.,Lesser Martin L.,Woloski B. M. R.,Bussel James B.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2001.02627.x/fullpdf

Reference10 articles.

1. Randomized trial of intravenous immunoglobulin G, Intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura;Blanchette;Lancet,1994

2. Treatment of acute idiopathic thrombocytopenia of childhood with intravenous infusions of gammaglobulin;Bussel;Journal of Pediatrics,1985

3. Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect;Bussel;Blood.,1991

4. Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rho (D) immune globulin intravenous administration in immune thrombocytopenic purpura patients;Gaines;Blood,2000

5. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology;George;Blood,1996

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Immune Thrombocytopenia: Contextualization from a Historical Perspective;Hematology Reports;2024-06-26

2. Primary Immune Thrombocytopenic Purpura (ITP) and ITP Associated with Systemic Lupus Erythematosus: A Review of Clinical Characteristics and Treatment Modalities;International Journal of Rheumatology;2024-03-01

3. IMMUNE THROMBOCYTOPENIC PURPURA: A HAEMATOLOGICAL DISORDER;International Journal of Pharmacy and Pharmaceutical Sciences;2024-01-01

4. How we treat primary immune thrombocytopenia in adults;Journal of Hematology & Oncology;2023-01-19

5. Why should intramuscular anti‐D be different from intravenous anti‐D?;British Journal of Haematology;2022-11-21